China's rapid development in the medical field in recent years is obvious to all, and the technology in oncology medicine has also been relatively mature. The establishment of Precise prevention, diagnosis and treatment plan and clinical decision-making system of tumor risk assessment, prediction and early warning, early screening, classification and classification, individualized treatment, efficacy and safety prediction and monitoring have become important research contents of precision medicine.

Lyndra's LYN-014 opioid use disorder project is supported by the National Institute of Drug Abuse under the National Institutes of Health as part of a long-term initiative to help end addiction.

On December 4, according to foreign media reports, Lyndra Biomedical Co., Ltd. of the United States announced that it has successfully developed a female monthly contraceptive and has completed animal experiments.